#CONy16 – Exclusive Interview with Dr. Heinz Reichmann

(5:51)

#CONy16 - Exclusive Interview with Dr. Florian Deisenhammer

(5:4)

#CONy16 - Exclusive Interview with Dr Michael Geschwind

(5:51)

#CONy16 – Exclusive Interview with Dr. Warren Olanow

(6:9)

#CONy16 - Exclusive Interview with Professor Xavier Montalban

(3:25)

#CONy16 Exclusive Interview with Professor Amos Korczyn, Co-Chairperson

(6:14)

#CONy16 - Exclusive Interview with Professor Victor Oliveira

(3:2)

Better understanding MS disease progression and monitoring

(3:47)

CONy 2022 Multiple Sclerosis Interview with Prof. Amos Korczyn and Prof. Klaus Schmierer

(5:58)

Cemcat, English

(4:9)

Alpha-synuclein inhibitors, kinase inhibitors \u0026 targeting mitochondria in Parkinson’s disease

(2:5)

Amos Korczyn 2016

(3:52:29)

Predicting treatment effect in MS patients: enrichment of certain baseline features in responders

(1:34)

Annual Report 2015: new drug to reduce progression of primary progressive multiple sclerosis

(2:11)

Unmet needs in Parkinson's disease

(2:31)